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Embryonic Stem Cell Research:
When Should It Be Allowed?
by Collin D. Zundel1

E

mbryonic stem cell research is a greatly debated subject. Proponents see it as an opportunity to help those with serious diseases, while opponents believe the research process destroys
precious life. The purpose of this paper is to create a rule outlining
in which cases embryonic stem cell research should be permitted.
Opposing sides can come to a compromise when the research is permitted under certain criteria. Embryonic stem cell research should
only be allowed when humans are not killed or severely harmed,
when intended to cure serious illness or injury, when there is consent
from the donor, and when accredited scientific researchers conduct
it. This essay will first discuss the background of embryonic stem
cell research, including the controversy and government involvement. Next, it will breakdown and discuss the elements of the rule,
discussing and applying when stem cell research should be permitted. Finally, the paper will discuss an alternative form of research
which does not use embryonic stem cells, but instead obtains stem
cells from adults.

I. The Background
At the end of 1998, it was announced that James A. Thompson
and his colleagues from the University of Wisconsin were able to
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successfully isolate embryonic stem cells.2 This breakthrough discovery marked the beginning of the stem cell controversy, a controversy that has been a hotly debated topic for many years. While stem
cells have been a highly discussed subject, the issue is perhaps deeper and more complicated than a surface discussion may conclude.
One fact about stem cells is that they are pluripotent, which means
they are capable of turning into any cell type.3 They are also infinite,
meaning they can divide an infinite number of times, whereas other
cells divide only a finite number of times.4 A cell, such as a stem cell,
which is both pluripotent and infinite, has the potential to turn into
any type of cell or organ. This means a stem cell holds the ability
to become a heart cell, lung cell, red blood cell, or any other type of
cell for the body. Scientists see enormous possibilities in a cell with
these two special characteristics. They believe that embryonic stem
cell research will bring about therapies that will possibly treat and
cure stroke, diabetes, Alzheimer’s disease, Parkinson’s disease, and
many other currently incurable diseases.5
A stem cell has the unique capacity to renew itself indefinitely and turn into specialized cell types.6 To obtain this special
form of cell, stem cells are taken from the blastocyst in embryos
and fetal tissue. A blastocyst is a group of cells called the inner
cell mass, which is a part of the early embryo. The blastocyst contains about two hundred to two hundred and fifty cells. Obtaining
embryonic stem cells from a blastocyst results in the destruction
of the embryo. Stem cell research that results in the destruction of
human embryos is what brings up many ethical concerns.7
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As a result of the embryonic stem cell debate, President Bill Clinton asked the National Bioethics Advisory Commission (NBAC) to
conduct research on the issue. The NBAC published its report in
1999 and 2000.8 They covered scientific, legal, ethical, religious, and
public policy perspectives as well as policy recommendations for
stem cell research. After the publication of the report, the Clinton
administration permitted federal funding for stem cell research using aborted fetal tissue, placentas, umbilical cord blood, and adult
stem cells. The Clinton administration also provided funding for research of stem cells obtained from frozen embryos, also known as in
vitro embryos. These in vitro embryos were created for the purpose
of fertility treatments and were in excess of clinical need. This new
policy did not stop the debates because many were unhappy with the
Clinton administration’s decision regarding embryonic stem cell research. They disagreed with the distinction made between destroying embryos for research purposes and using previously derived
embryonic stem cells for research.9
President George W. Bush announced a conservative change on
August 9, 2001.10 The change provided that federal funds would be
given if three criteria were met.11 First, that the derivation process,
which begins with the destruction of the embryo, must have been
initiated prior to nine o’clock P.M. EDT on August 9, 2001. Second,
the stem cells must have been derived from an embryo that was created for reproductive purposes and was no longer needed. Third,
informed consent must be obtained for the donation of the embryo
from the person who possessed the embryo, and that donation must
not have involved financial inducements.12 Federal funds were allocated to adult stem cell research and research using stem cells taken
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from umbilical cord blood and placentas. Federal funding would not
go to research involving the creation or destruction of human embryos. President Bush’s decision did not touch the issue of using aborted
fetal tissue for stem cell research. Research using aborted fetal tissue
continued to be eligible for federal funding.13
There are various debates between the ethical and scientific
sides of embryonic stem cell research. Since embryos are potential
humans, an important question is whether using stem cells derived
from embryos should be considered murder. Arguing that embryonic research is murder, Senator Sam Brownback addressed Congress on June 29, 2006.14 He says that in our legal system embryonic
stem cells are either a person or a piece of property. The law does
not observe a transition from property to personhood because there
is no dividing line. If you start out as a human being, then you will
end up as a human being. If something has the potential to be human
life, then it can never be property. He believes that once the process
of life begins, it is human life from then on. Therefore, once it has
been started, it is murder to stop the process of an embryo becoming
a human.15
Giving a very different view, Senator Byron Dorgan addressed
Congress on July 10, 2006.16 He said research that can find cures to
diseases such as Alzheimer’s, Parkinson’s, heart disease, and diabetes must be a priority. More than one million people have been
born through in vitro fertilization. However, fertility clinics fertilize
many more eggs than are actually implanted in a woman’s uterus.
These clinics across the nation contain approximately four hundred
thousand cryogenically frozen embryos. Eight thousand to ten thousand of these frozen embryos are simply discarded every year. This
does not amount to murder any more than embryonic stem cell research. Those embryos will never become human beings because
13
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they are not implanted in a woman’s uterus. Senator Dorgan believes
this issue is about giving new life and opportunities to those who
are suffering from disease.17 These two opinions are good examples
of the opposing views between ethics and science. Both sides make
important points that are necessary in the formulation of the rule.

II. The breakdown and discussion of the Criteria
In what cases should embryonic stem cell research be permitted? The rule stated earlier says that embryonic stem cell research
should only be permitted when it does not kill or severely harm humans, when it is intended to cure disease or injury, when there is
consent from the donor, and when it is conducted by accredited scientific researchers. This is still somewhat ambiguous and will need
to be broken down to give the rule more clarity. For this purpose, it
is necessary to define several key elements of the rule.
The first part of the rule says that stem cell research should not
kill or severely harm humans. To “kill” would mean anything that
ends human life.18 “Severe harm” means any measure that may have
severe negative side effects, cause serious injury, or exploit humans.19 The third important part of this element is the definition
of human life. This would mean a human at any stage of life, including a viable embryo. A viable embryo is one that is implanted
in a woman’s uterus.20
The next criterion says the research must be intended to cure
serious disease or injury. This means that the intention of embryonic
stem cell research does not include reproductive cloning or therapeu-
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tic cloning. This condition narrows the instances when this research
should be permitted.
The rule also says that research should only be allowed when
there is consent from the donor. This would mean that consent
must be obtained from those who are giving the stem cells. In the
case of embryonic stem cells, it would include the donors of the
egg and sperm.
The last criterion is that accredited scientific researchers must
conduct the research. Only certain people can do research with
stem cells. A scientist must be accredited through schooling and
experience to be allowed to conduct the research. They must be
trained scientists and doctors who have gone through the proper
steps of schooling.
Proponents strongly in favor of embryonic stem cell research
would argue that nothing is killed. They do not believe that a fiveto seven-day-old embryo is a human life. This brings up the question of when life actually begins during human development. Many
people believe that an embryo is not a human life until birth, others
believe that life begins at conception, and others believe life begins
somewhere between conception and birth. These questions are not
answerable by objective evidence. The argument should turn more
to the potential of an embryo. When an embryo is implanted in the
uterus, it has the potential to grow to be a full human being. When
an embryo is on its way to this goal, it should not be interrupted. To
not interrupt this process, the rule states that stem cell research must
not result in the destruction of the embryo.
In order not to destroy viable embryos, researchers turn to excess in vitro fertilization for embryonic stem cell research. There
are clinics all across the country that have excess in vitro embryos,
which comes from couples who have donated eggs and sperm for
the purpose of their own familial development.21 There are many in
vitro embryos left behind that couples will no longer need. Therefore, the question is raised of what to do with unused in vitro embryos. Many feel that excess in vitro embryos should be donated to
other couples who may not have the capability of providing eggs and
21
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sperm.22 Although this is the preferable solution, the supply is more
in excess than can be used by couples in need.23 Also, couples may
not be comfortable with someone else using their embryo to have a
baby. An alternative solution to supplying couples in need or simply
discarding the embryos would be to donate the embryos to science
for the use of embryonic stem cell research.24 If the embryos are used
for research instead, they could be used to potentially cure serious
disease or injury.
Stem cell research should be limited to the condition of curing serious disease or injury. Stem cells have the potential to treat
spinal cord injuries and diseases such as leukemia and diabetes
among others.25 Embryonic stem cells have the possibility to cure
injuries and diseases for which there was previously no treatment.
The sensitivity of embryonic stem cells coupled with its major
possibilities makes it reasonable for its allowance with limitations. Through limitations and regulations, the nature of life will
be protected, and researchers will be prevented from pursuing
their own selfish interests.
The consent from the donor is essential because it prohibits
manipulating people in order to conduct research without their permission. People should have a say when their property is used for
research. This ensures that those who are against embryonic stem
cell research will have no part in it. It is also important that only
accredited scientific researchers and doctors conduct the research.
Only those who are specially trained should be allowed to conduct
the research. This bans people from trying to conduct the research
without the necessary qualifications. Regulating the researchers will
preserve the precious stem cells that are available and will help to
ensure that they are taken seriously and not wasted. The last two
parts of the rule make it complete and allow for the progress of research and the preservation of human life.
22
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III. Application of the Four Criteria
The rule can now be further illustrated through test cases as it
has been properly defined. The first example is with two doctors
who have been researching at a reputable medical school for a number of years. They were among the first to take the lead in stem cell
research and have given a number of lectures promising its results.
They have put their reputations at risk saying that new cures will
be coming for problems like Parkinson’s disease and severe spinal
cord injuries. They have asked several pregnant women who do not
want to continue in their pregnancy to come in. Their research has
proved promising, but they have not yet come up with a way for doing the research without destroying the fetus in the woman’s uterus.
Both doctors feel that the benefit of the stem cell research will far
outweigh the cost of destroying the embryos.
This case could be somewhat controversial because the doctors
have had some promising results. There is evidence the research
is being conducted by accredited scientific researchers as it is performed at a medical institution. Also, the researchers are performing
research for the right purpose of curing disease and serious injury.
However, the research is being performed at the cost of human life.
They are destroying viable human embryos. Although the doctors
are justifying their research, it still falls short of the rule created
earlier. The fact that it falls short for just one part of the rule makes
the research in this case unacceptable.
The next case is of a pregnant twenty-four year old. She has just
found out she is pregnant and has decided not to keep the baby. She
has met with her doctor, and together they decided to abort the fetus.
The doctor suggests that the fetus be used for stem cell research. He
explains to her that the stem cells will be studied and used to help
people who have disease or are seriously injured. The embryo will
be destroyed, but the stem cells will be used for research purposes.
She agrees to participate in the research and allows them to take the
embryonic stem cells.
This case is more controversial because it brings up the question
of what to do with embryos that will be destroyed no matter what.
This case satisfies all the criteria of the rules except for the killing
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of a viable embryo. The fact that she is aborting the fetus is already
controversial because human life is destroyed. The destruction of life
is not for the purpose of embryonic stem cell research. The embryo
should be used for stem cell research because it will be destroyed no
matter what. Another example of this would be of a murdered person
donating organs. The donated organs do not sanction the murder just
as taking stem cells does not sanction the abortion. Though life is
being lost, the bodily organs can provide help to those in need. This
example therefore satisfies all the criteria of the rule.
The third example is of a young married couple. They have
wanted to become pregnant for a long time but have been unable.
They decided to use the process of in vitro fertilization to become
pregnant. The process was a success and the wife is now pregnant.
The excess in vitro embryos will be discarded because they can no
longer be used to help anyone become pregnant. The doctor tells
the couple that the excess in vitro embryos can be used for stem
cell research to help those with disease and serious injury. They
decide to donate their excess in vitro embryos to a reputable medical research program.
This case seems to satisfy all of the requirements to allow for
stem cell research under the proper conditions. The research is not
killing or harming viable human embryos. It is intended for the right
purpose of helping those with disease and injury. It was given with
the consent of the donor, and will be performed by accredited scientific researchers. This research should be allowed according to the
criteria of the rule.
The rule for stem cell research applies to the different cases that
have been presented. It is reasonable to assume that the rule will
hold for even the most difficult cases. Embryonic stem cell research
should only be performed when no one is killed or harmed, when
accredited professionals conduct the research, when there is consent,
and when it is for the right purpose. A strong base is formed when
creating and applying the different elements of the rule. Stem cell
research will most likely continue to be a highly debated subject. It is
important to consider its possibilities coupled with the sensitivity of
human life. The medium between limitations and its allowance will
bring about much progress in the future.
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IV. Other Alternatives
Many people argue that adult stem cell research is just as effective as embryonic research and does not raise the same ethical concerns that embryonic research raises. David A. Prentice, Professor
of Life Sciences at Indiana State University, says that despite twenty
years of experiments with mouse embryonic stem cells and the fervor that has arisen regarding human embryonic stem cells, their advantage over adult stem cells are unsubstantiated. He further points
out that there is “no current clinical treatment using embryonic stem
cells.”26 There are few and modest advances with embryonic stem
cells in animal models of disease, and there is difficulty obtaining
pure cultures in the laboratory dishes. He says the stem cells themselves are even difficult to maintain in culture. Proponents of embryonic stem cell research admit that potential treatments run the risk
of immune rejection by the patient and of tumor formation. He also
points out that a report from 2001 states that “embryonic stem cells
are genomically unstable, exhibiting variable gene expression even
in the controlled conditions of the laboratory.”27 If adult stem cell
research can be proven to be more promising than embryonic stem
cell research, then, in the future, we may have good reason to focus
entirely on adult stem cells.
William B. Slayton, of the Department of Pediatrics, College of
Medicine at the University of Florida, and Gerald J. Spangrude, of
the Department of Oncological Sciences at the University of Utah,
give an overview of adult stem cells in their essay called “Adult Stem
Cell Plasticity.”28 They say that adult stem cells may provide “solutions that avoid the legal and ethical problems of cloning and fetal
stem cell approaches.”29 Until recently, popular belief held that adult
26
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stem cells were restricted in their ability to produce tissue different
from their original source tissue. Studies have shown that adult stem
cells are plastic, meaning they can differentiate into their own source
tissue and also unrelated tissue. However, Slayton and Spangrude
outline four current controversies involving adult stem cell plasticity.30 The first is that plasticity has been inferred from an undefined
mixture of cells. It is therefore unclear which cells give rise to the
new types and whether separate cell lineages arise from the same
cell. The second problem has to do with the culture period. They say
it becomes unclear whether the stem cells, as originally isolated, had
the ability to produce the results or whether modifications occurred
because of the period. The third problem is that most studies have
not shown the ability of transdifferentiating stem cells to self-renew.
Finally, most studies have not shown the functionality of transdifferentiated stem cells. In summary, these problems demonstrate that
science has not furnished sufficient evidence for adult stem cell plasticity.31 Much work is necessary to confirm that the cells exhibiting
plasticity are the adult stem cells. They conclude that focusing only
on adult stem cell research and ignoring the potential of embryonic
stem cells may lead to missed opportunities. Each approach has the
possibility of being advantageous in certain clinical situations.32 It is
important to take this article into consideration because both aspects
of stem cell research show potential and deserve attention.

V. Conclusion
This short paper has discussed the background of embryonic
stem cell research and the reasons it has become a controversial subject in the United States. A rule was proposed that embryonic stem
cell research should only be permitted when it does not kill or severely harm humans, when it is intended to cure serious disease, when
there is consent, and when it is conducted by accredited scientific
researchers. The rule was further explained and then outlined in a
30
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number of test cases where it was found to apply. Finally, this review
discussed other alternatives of stem cell research. Although these
other methods have potential, many agree that researchers should
still explore the potential of embryonic stem cells. This has been a
controversial subject, but both sides of the debate have justification.
Compromising on the subject may be the only way to preserve and
enhance life in both cases.

